Support
Our Retatrutide is tested by Janoshik Analytical, an independent laboratory, using a blind GLP-1 panel — they screened for Semaglutide, Tirzepatide and Retatrutide without being told which compound was submitted. Results were 99.401% (10mg), 99.602% (20mg) and 99.658% (30mg), with every vial exceeding its labelled content. Certificates are published at /coa/ and can be verified directly on Janoshik's own website. View the certificates.